A case of severe parkinsonism associated with short-term treatment with milnacipran

Clinical Neuropharmacology

Volumn 31, Issue 5, 2008, Pages 299-300

  Muraoka, Toshifumi ^a   Oku, Eisaku ^a   Sugataka, Kazuhiro ^a   Yamada, Shigeto ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

MIBG; Depression; Milnacipran; Parkinsonism

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 125; CARBIDOPA PLUS LEVODOPA; FLUVOXAMINE; LEVODOPA; MIANSERIN; MILNACIPRAN; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; CYCLOPROPANE DERIVATIVE;

ADD ON THERAPY; ADULT; ARTICLE; CASE REPORT; DEPRESSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG UPTAKE; DYSURIA; FEMALE; GAIT DISORDER; HUMAN; LIVER DYSFUNCTION; LOW DRUG DOSE; MUSCLE RIGIDITY; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; REMISSION; TREATMENT DURATION; TREMOR; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TIME;

CYCLOPROPANES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MIDDLE AGED; PARKINSONIAN DISORDERS; TIME FACTORS;

EID: 65849152219     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31815947c7     Document Type: Article

References (8)

1. Caley CF. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors. Ann Pharmacother 1997;31:1481-1489.
2. Gonul AS, Aksu M. SSRI-induced parkinsonism may be an early sign of future Parkinson's disease. J Clin Psychiatry 1999;60:410.
3. Frechilla D, Cobreros A, Saldise L, et al. Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys. Synapse 2001;39:288-296.
4. Arai M. Parkinsonism associated with a serotonin and noradrenaline reuptake inhibitor, milnacipran. J Neurol Neurosurg Psychiatry 2003;74:137-138.
5. Kashihara K, Ohno M, Kawada S, et al. Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies. J Nucl Med 2006;47:1099-1101.
6. Spiegel J, Mollers MO, Jost WH, et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005;20:552-561.
7. Lee PH, Kim JS, Shin DH, et al. Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry 2006;77:372-374.
8. Takahashi H, Kamata M, Yoshida K, et al. Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports. Prog Neuropsychopharmacol Biol Psychiatry 2005;29: 351-353.